Cerberus Ventures leads financing alongside five physician users of Virchow’s biopsy technologies LA JOLLA, Calif.--(BUSINESS WIRE)--March 24, 2026-- ...
Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...
Medical Device Network on MSN
Vaxess Technologies raises $50m, rebrands to Terrestrial Bio
Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.
Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results